Driving Treatments for FOXG1 Syndrome and Rare Diseases : The FOXG1 Research Foundation

The FOXG1 Research Foundation (FRF) is a parent-led global organization advancing the first treatment for FOXG1 syndrome—a promising gene therapy—to patients with FOXG1 syndrome around the world. Determined to give our children a healthier future, FRF is transforming the rare disease drug development landscape with an innovative model that drastically cuts the timeline and costs of bringing life-changing treatments to patients. Our "Yes, They Can!" campaign is in full swing to make this breakthrough therapy accessible to children worldwide—turning “no, they can’t” into “Yes, they can!”